Inventor · disambiguated record
Haishan Luo
Also filed as: LUO HAISHAN
2 granted patents·5 pending applications·2 citations·filing 2016–2023
36Inventor score
Files withHARBOUR BIOMED SHANGHAI CO LTD4JIANGSU HYAMAB PHARMACEUTICAL CO LTD1NONA BIOSCIENCES SUZHOU CO LTD1PHARMAEXPLORER LTD1
Top patents by PatentIndex Score
7 records- 0167US10889648B2Anti-PD-L1 antibodies and uses thereofJIANGSU HYAMAB PHARMACEUTICAL CO LTD·Filed 2016·Granted Jan 12, 2021·2 cites·15 claims
- 0256US2025215100A1Antigen binding protein targeting cd40, and preparation therefor and use thereofHARBOUR BIOMED SHANGHAI CO LTD·Filed 2023·Application pending·0 cites
- 0352US2025215089A1Antigen-binding protein targeting pd-l1 and cd40, preparation therefor, and use thereofHARBOUR BIOMED SHANGHAI CO LTD·Filed 2023·Application pending·0 cites
- 0450US2024269276A1Specific binding protein targeting pd-l1 and cd73HARBOUR BIOMED SHANGHAI CO LTD·Filed 2022·Application pending·0 cites
- 0549US2025154268A1Antibody targeting cd25, and preparation method therefor and use thereofNONA BIOSCIENCES SUZHOU CO LTD·Filed 2023·Application pending·0 cites
- 0649US2023322953A1Binding protein having h2l2 and hcab structuresHARBOUR BIOMED SHANGHAI CO LTD·Filed 2021·Application pending·0 cites
- 0739US10973915B2Anti-PD-1 antibodies and uses thereofPHARMAEXPLORER LTD·Filed 2016·Granted Apr 13, 2021·0 cites·15 claims
Join the waitlist — get patent alerts
Get an alert when Haishan Luo files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →